411 related articles for article (PubMed ID: 30617737)
1. Therapeutic Approaches to Alzheimer's Disease Through Modulation of NRF2.
Bahn G; Jo DG
Neuromolecular Med; 2019 Mar; 21(1):1-11. PubMed ID: 30617737
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of early upstream events in prodromal Alzheimer's disease by use of targeted antioxidants.
Prasad KN; Bondy SC
Curr Aging Sci; 2014; 7(2):77-90. PubMed ID: 25101711
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
[TBL] [Abstract][Full Text] [Related]
4. Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy.
Joshi G; Gan KA; Johnson DA; Johnson JA
Neurobiol Aging; 2015 Feb; 36(2):664-79. PubMed ID: 25316599
[TBL] [Abstract][Full Text] [Related]
5. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease.
Ali T; Kim T; Rehman SU; Khan MS; Amin FU; Khan M; Ikram M; Kim MO
Mol Neurobiol; 2018 Jul; 55(7):6076-6093. PubMed ID: 29170981
[TBL] [Abstract][Full Text] [Related]
6. Activation of Nrf2/ARE pathway alleviates the cognitive deficits in PS1V97L-Tg mouse model of Alzheimer's disease through modulation of oxidative stress.
Tian Y; Wang W; Xu L; Li H; Wei Y; Wu Q; Jia J
J Neurosci Res; 2019 Apr; 97(4):492-505. PubMed ID: 30461032
[TBL] [Abstract][Full Text] [Related]
7. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
8. Dual-energy precursor and nuclear erythroid-related factor 2 activator treatment additively improve redox glutathione levels and neuron survival in aging and Alzheimer mouse neurons upstream of reactive oxygen species.
Ghosh D; LeVault KR; Brewer GJ
Neurobiol Aging; 2014 Jan; 35(1):179-90. PubMed ID: 23954169
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor NRF2 as a promising therapeutic target for Alzheimer's disease.
Qu Z; Sun J; Zhang W; Yu J; Zhuang C
Free Radic Biol Med; 2020 Nov; 159():87-102. PubMed ID: 32730855
[TBL] [Abstract][Full Text] [Related]
10. Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.
Fão L; Mota SI; Rego AC
Ageing Res Rev; 2019 Sep; 54():100942. PubMed ID: 31415806
[TBL] [Abstract][Full Text] [Related]
11. CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis.
Wang CY; Wang ZY; Xie JW; Cai JH; Wang T; Xu Y; Wang X; An L
Antioxid Redox Signal; 2014 Dec; 21(16):2208-30. PubMed ID: 24702189
[TBL] [Abstract][Full Text] [Related]
12. Brain Dicer1 Is Down-Regulated in a Mouse Model of Alzheimer's Disease Via Aβ42-Induced Repression of Nuclear Factor Erythroid 2-Related Factor 2.
Wang Y; Lian M; Zhou J; Wu S
Mol Neurobiol; 2020 Nov; 57(11):4417-4437. PubMed ID: 32737764
[TBL] [Abstract][Full Text] [Related]
13. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
Sivandzade F; Prasad S; Bhalerao A; Cucullo L
Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
[TBL] [Abstract][Full Text] [Related]
14. Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model.
Wang CY; Wang ZY; Xie JW; Wang T; Wang X; Xu Y; Cai JH
Neurobiol Aging; 2016 Feb; 38():32-46. PubMed ID: 26827641
[TBL] [Abstract][Full Text] [Related]
15. Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.
Tapias V; Jainuddin S; Ahuja M; Stack C; Elipenahli C; Vignisse J; Gerges M; Starkova N; Xu H; Starkov AA; Bettendorff L; Hushpulian DM; Smirnova NA; Gazaryan IG; Kaidery NA; Wakade S; Calingasan NY; Thomas B; Gibson GE; Dumont M; Beal MF
Hum Mol Genet; 2018 Aug; 27(16):2874-2892. PubMed ID: 29860433
[TBL] [Abstract][Full Text] [Related]
16. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases.
Joshi G; Johnson JA
Recent Pat CNS Drug Discov; 2012 Dec; 7(3):218-29. PubMed ID: 22742419
[TBL] [Abstract][Full Text] [Related]
17. Nrf2: a dark horse in Alzheimer's disease treatment.
Osama A; Zhang J; Yao J; Yao X; Fang J
Ageing Res Rev; 2020 Dec; 64():101206. PubMed ID: 33144124
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 Suppresses Oxidative Stress and Inflammation in
Uruno A; Matsumaru D; Ryoke R; Saito R; Kadoguchi S; Saigusa D; Saito T; Saido TC; Kawashima R; Yamamoto M
Mol Cell Biol; 2020 Feb; 40(6):. PubMed ID: 31932477
[TBL] [Abstract][Full Text] [Related]
19. The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities.
De Plano LM; Calabrese G; Rizzo MG; Oddo S; Caccamo A
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979483
[TBL] [Abstract][Full Text] [Related]
20. Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease.
Branca C; Ferreira E; Nguyen TV; Doyle K; Caccamo A; Oddo S
Hum Mol Genet; 2017 Dec; 26(24):4823-4835. PubMed ID: 29036636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
